Treatment of ocular conditions utilizing a histone/protein deacetylase inhibitor
Abstract:
A method for treating an ocular disorder in a subject comprising administering a therapeutic agent-loaded carrier to an ocular site of the subject in need thereof, wherein the therapeutic agent is a histone deactylase inhibitor.
Information query
Patent Agency Ranking
0/0